08:36 AM EDT, 07/31/2024 (MT Newswires) -- United Therapeutics ( UTHR ) reported Q2 net income Wednesday of $5.85 per diluted share, up from $5.24 a year earlier.

Analysts polled by Capital IQ expected $6.40.

Revenue for the quarter ended June 30 was $714.9 million, compared with $596.5 million a year earlier.

Analysts surveyed by Capital IQ expected $690.9 million.

Shares of the company were down 4.3% in recent premarket activity.

Price: 322.90, Change: -14.64, Percent Change: -4.34